Therefore, coupling the blocking of cancer epigenetic regulator (HDAC6) and ICI (VISTA) with Bexarotene and Oxymorphone is an unprecedented way to aggressively limit cancer pathogenicity that deserves experimental validation. Here, HDAC6 is linked to cancer.